A little over a year ago, the UK confirmed its first case of COVID-19. Since then, we have collectively endured months of uncertainty and lockdowns whilst scientists worldwide endeavoured to create a…
The Society welcomes publication of the Scottish Government’s new ‘Heart disease: action plan’. The action plan sets out the Government’s priorities and the actions they will take to minimise…
The British Pharmacological Society have partnered with Zinc Media to produce a series of complementary and informative films. These films will celebrate innovation and collaboration across the…
In its recent spending review, the government announced investment of £14.6 billion in R&D in 2021-22, building on commitments to increase public R&D investment to £22 billion per year by…
As the season shifts from winter to spring in the UK, many of us are looking forward to the gradual easing of lockdown restrictions and the chance to connect, as per Government guidelines, with…
Today, 5 April 2021, updated guidance on good practice in prescribing and managing medicines and devices, published by the General Medical Council (GMC) comes into force. The guidance supports…
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new advice, concluding a possible link between the Oxford-AstraZeneca COVID-19 vaccine and extremely rare,…
The joint seminar and workshop from the British Pharmacological Society, Laboratory Animal Science Association (LASA) and Psychiatry Consortium was held on the 24th and 25th of February 2021, with…
Update: We received a number of excellent applications to join the group. However, we are still looking for at least one undergraduate/postgraduate member. We would also like to have at least one…
I joined the publications team at the British Pharmacological Society in early 2017 as I was interested in the process of publishing academic journals as an avenue for communicating science. I…
